SUTRO BIOPHARMA, INC.

STRO · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.6B · 137 employees
144
SEC Filings
$11.255
Close 2026-10-19
137
Employees

Business Summary

Sutro Biopharma is a clinical stage oncology company developing site-specific antibody drug conjugates (ADCs) enabled by its proprietary XpressCF cell-free protein synthesis platform and XpressCF+ conjugation platform. Its lead product candidate, STRO-004, is a tissue factor-targeting ADC in Phase 1 for solid tumors. Preclinical assets include STRO-227 (PTK7 dual-payload ADC) and STRO-006 (ITG6 ADC). The company has entered collaborations with Astellas, Merck, BMS/Celgene, and EMD Serono for iADCs, cytokine derivatives, BCMA ADCs, and MUC1-EGFR ADCs, and has received approximately $1.016 billion in aggregate collaboration payments through December 31, 2025.

Latest Stock Quote

STRO 2026-10-19 $11.255 O:$11.01 H:$11.46 L:$10.75 Vol:0.3M VWAP:$11.1718
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-14

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-232025-12-310001193125-26-119873EDGAR106K words
2025-03-132024-12-310000950170-25-038884EDGAR103K words
2024-03-252023-12-310000950170-24-035949EDGAR112K words
2023-03-302022-12-310000950170-23-010976EDGAR113K words
2022-02-282021-12-310000950170-22-002312EDGAR108K words
2021-03-182020-12-310001564590-21-013945EDGAR106K words
2020-03-162019-12-310001564590-20-010890EDGAR100K words
2019-04-012018-12-310001564590-19-010253EDGAR100K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-122026-09-300001193125-26-458680EDGAR72K words
2026-08-122026-06-300001193125-26-345748EDGAR71K words
2025-11-062025-09-300001193125-25-270036EDGAR71K words
2025-08-072025-06-300000950170-25-105219EDGAR70K words
2025-05-082025-03-310000950170-25-067072EDGAR66K words
2024-11-132024-09-300000950170-24-126407EDGAR71K words
2024-08-132024-06-300000950170-24-096336EDGAR70K words
2024-05-132024-03-310000950170-24-058718EDGAR67K words
2023-11-132023-09-300000950170-23-063037EDGAR77K words
2023-08-102023-06-300000950170-23-041416EDGAR74K words
2023-05-152023-03-310000950170-23-021976EDGAR69K words
2022-11-082022-09-300000950170-22-023279EDGAR74K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-120001193125-26-458641EDGAR2K words
2026-08-120001193125-26-345733EDGAR3K words
2026-03-230001193125-26-119844EDGAR3K words
2026-02-100001193125-26-044934EDGAR3K words
2025-12-170001193125-25-322859EDGAR1K words
2025-12-030001193125-25-306786EDGAR1K words
2025-11-060001193125-25-269833EDGAR2K words
2025-09-290001193125-25-223434EDGAR1K words
2025-08-070000950170-25-105159EDGAR2K words
2025-06-250000950170-25-089978EDGAR1K words

144 total filings indexed. 114 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

oncology solid-tumors antibody-drug-conjugates cell-free-protein-synthesis immunostimulatory-adcs dual-payload-adcs cgmp-compliant-cell-free-protein-synthesis site-specific-conjugation non-natural-amino-acid-incorporation

Company Identity

CIK0001382101
TickerSTRO
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
Websitehttps://www.sutrobio.com
Listed2018-09-27

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 6c47e16c061d89a80d0da678ae3f6aa4fd02b3744694fc49c461db5b90a93e06
parent: 186861b57d2beac0a9001a8fff69824ae4765bdd68052b114c585ed6a0a8ef9c
content hash: d7abbf336035f3c03b42cbd9a8b93eec10316d008fe0b0e741572b41a501e90d
signed: 2026-11-16T19:04:57.902Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up STRO using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on STRO, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/STRO (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.